Thrombosis Research

Top Research Topics at Thrombosis Research?

The primary areas of discussion in Thrombosis Research are Internal medicine, Platelet, Biochemistry, Endocrinology and Immunology. Topics in Internal medicine were tackled in line with various other fields like Gastroenterology, Surgery and Cardiology. Specifically, studies on Pulmonary embolism are prevalent in the Surgery works discussed.

In it, Anesthesia, Whole blood, Aspirin and Pharmacology are investigated in conjunction with one another to address concerns in Platelet research. Pharmacology research presented in Thrombosis Research encompasses a variety of subjects, including Anticoagulant, In vivo and Antithrombotic. Topics in Biochemistry explored in it were investigated in conjunction with research in Molecular biology, Thrombin and Fibrin.

It focuses on Immunology but the discussions also offer insight into other areas such as Coagulation and Tissue factor. Presentations on Heparin include those discussing Antithrombin and Low molecular weight heparin. The studies tackled, which mainly focus on Thrombosis, apply to Thrombus as well.

• Internal medicine (37.31%)
• Platelet (21.66%)
• Biochemistry (16.93%)

What are the most cited papers published in the journal?

• Incidence of thrombotic complications in critically ill ICU patients with COVID-19. (2422 citations)
• Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. (1010 citations)
• Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. (809 citations)

Research areas of the most cited articles at Thrombosis Research:

The main points discussed in the published articles deal with Internal medicine, Platelet, Biochemistry, Endocrinology and Immunology. While work presented in the most cited publications provide substantial information on Internal medicine, it also covers topics in Gastroenterology, Surgery and Cardiology. The journal articles explore research in Pharmacology and overlapping concepts in Antithrombotic to expand the discourse in Platelet.

What topics the last edition of the journal is best known for?

• Internal medicine
• Enzyme
• Biochemistry

The previous edition focused in particular on these issues:

The journal investigates studies in Internal medicine, Venous thromboembolism, Thrombosis, Cancer and Coronavirus disease 2019 (COVID-19). The featured Internal medicine research zeroes in on concepts in Pulmonary embolism but also tackles themes under In patient. Venous thromboembolism research presented in Thrombosis Research encompasses a variety of subjects, including Rivaroxaban, Incidence (epidemiology), Cohort study and Intensive care medicine.

Topics in Incidence (epidemiology) were tackled in line with various other fields like Complication and Surgery. Deep vein and Venous thrombosis are Thrombosis topics of special interest in the journal. Thrombosis Research tackles research in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as part of the general discipline of Coronavirus disease 2019 (COVID-19), however, it also discusses concepts in 2019-20 coronavirus outbreak.

The most cited articles from the last journal are:

• Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. (22 citations)
• Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. (21 citations)
• Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. (17 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Thrombosis Research (based on the number of publications) are:

• Akikazu Takada (105 papers) absent at the last edition,
• Yumiko Takada (102 papers) absent at the last edition,
• Per Morten Sandset (98 papers) published 2 papers at the last edition the same number as at the previous edition,
• Jawed Fareed (82 papers) published 2 papers at the last edition,
• Walter Ageno (82 papers) published 3 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Thrombosis Research (based on the number of publications) are:

• McMaster University (310 papers) published 13 papers at the last edition, 3 more than at the previous edition,
• French Institute of Health and Medical Research (243 papers) published 9 papers at the last edition, 7 more than at the previous edition,
• Karolinska Institutet (211 papers) published 2 papers at the last edition, 3 less than at the previous edition,
• University of Oslo (185 papers) published 2 papers at the last edition, 6 less than at the previous edition,
• University of North Carolina at Chapel Hill (179 papers) published 3 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 32.76% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.06% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.26% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.67% of all publications and 58.01% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Thrombosis Research

For those aspiring to join the research community and contribute to thrombosis research, various gateways provide opportunities to apply your skills and expand your knowledge. The journey to becoming an active contributor to this field can start from any degree, but obtaining a higher degree like a Ph.D. or a medical degree, followed by specialized training in research on thrombosis, can provide an entry point to this field. A career in thrombosis research can include roles such as clinical researcher, medical scientist, pharmaceutical researcher, or research nurse. The choice of role will depend on your area of interest, your skillset, and your educational qualifications. Specifically, a role that combines clinical work with research is a career as a research nurse. Their role often involves coordinating clinical trials, collecting data, and assisting in medicinal breakthroughs. While this can be a fulfilling and exciting career path, it requires a specific set of qualifications and training. For instance, if one intends to become a research nurse in New Hampshire, you can follow our guide on how to become a registered nurse in New Hampshire to get started on your journey. In summary, thrombosis research offers diverse career opportunities to contribute to the scientific community's understanding and treatment of thrombosis. Armed with the right qualifications and a deep commitment to research, you can play a critical role in this fascinating, life-changing field.